HOME >> MEDICINE >> NEWS
Heart mapping technique safely guides catheter repair of arrhythmia

(Finalist presentation for Melvin Judkins Young Clinical Investigator Award, Room A309, Dallas Convention Center)

In experiments with dogs, Johns Hopkins researchers successfully used a 3D map of the heart and sensor-guided catheter to perform cardiac ablation, a mainstay treatment that stops abnormally fast and potentially fatal heartbeats, or arrhythmias.

The Hopkins findings, to be presented at the American Heart Association's Scientific Sessions 2005 on Nov. 13 in Dallas, Texas, provided information and technology used by the United States Food and Drug Administration to approve the system in March for testing in humans, now under way.

The Hopkins team created their own 3D models of each heart from images obtained by integrating and superimposing CT and MRI scans. Using an upgraded computer software program known as electro-anatomic mapping, the scientists are able to color-code the heart models' structures.

The scientists safely ablated, or destroyed, tiny areas of diseased heart tissue that facilitate rhythm disturbances, guided only by these anatomically precise, reconstructed 3D map.

During the procedure, a catheter containing a magnetic sensor in its tip is inserted through a vein in the dog's leg, then guided to the heart, where it is used to burn off the small part of heart muscle that gives rise to the errant signaling responsible for the arrhythmia.

A magnetic location pad was placed under the operating table and situated directly beneath the animal's body to detect the position of the catheter and compare it to the computer-generated image of the heart displayed on a screen.

"This is a significant improvement for patient safety and the performance of minimally invasive procedures in the heart," says study senior investigator and cardiologist Timm Dickfeld, M.D., Ph.D., an adjunct assistant professor at The Johns Hopkins University School of Medicine and its Heart Institute. Dickfeld
'"/>

Contact: David March
dmarch1@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
13-Nov-2005


Page: 1 2

Related medicine news :

1. Drug-eluting stent controversy explored in the American Heart Hospital Journal
2. Heart-failure patients benefit from pharmacist care
3. Study offers clues to Broken Heart Syndrome
4. Heart Failure 2007
5. Heart failure medication does not improve survival, compared to more widely used medication
6. UCLA neurologist honored with American Heart Associations Stroke Council Award
7. Heart failure: Mayo Clinic reveals abnormality in filling of the heart is frequent culprit
8. Heart catheters do not benefit patients
9. Heart Rhythm Society publishes final recommendations for heart patients
10. Heartburn drug may help to slow progression of chronic heart failure
11. Heart failure drugs may be beneficial for patients with hardening of the arteries

Post Your Comments:
(Date:5/18/2013)... Los Angeles, Ca (PRWEB) May 18, 2013 ... lot of people. But among the horde of new weight ... the one most talked about. Recent studies about this newest ... to achieve one’s ideal body shape. , Garcinia Cambogia is ... looks like a tamarind. Eating the fruit can suppress a ...
(Date:5/18/2013)... 2013 John Ravera, D.D.S., a Newport ... a new member to his dental team, Courtney Marino. , ... field for over 10 years. She received her degree from ... elected a member of Sigma Pi Alpha, a national honor ... working with patients of all ages, helping them understand the ...
(Date:5/18/2013)... Medical device company, FlexLeg, LLC, last week ... mobility aid with its namesake, the FlexLeg. The device ... alternative that injured individuals can use to walk on ... remain active and walk during a typical 6-8 week recovery ... to ensure those who need the device most are able ...
(Date:5/17/2013)... Lake City, Utah (PRWEB) May 17, 2013 ... by providing their corporate wellness programs to businesses ... This has been achieved through rigorous infrastructure ... a greater capacity for employee interactions via voice ... in helping businesses lower employee healthcare costs ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Johnson & ... it will stop sales of metal-on-metal hip replacements. This ... products drop significantly* amid lawsuits and calls for increased ... ASR hip implant. The Rottenstein Law Group LLP, a ... remove these products from the market and notes that ...
Breaking Medicine News(10 mins):Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:FlexLeg Begins Offering New Mobility Aid 2Health News:New Telecommunications Upgrade Provides More Capacity for National Corporate Wellness Programs offered by Orriant 2Health News:DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP 2Health News:DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP 3
(Date:5/17/2013)... , May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... that Kyle Guse , Chief Financial Officer ... LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hotel. The Company,s presentation is scheduled to ... a live webcast. To access the webcast, go to ...
(Date:5/17/2013)... 2013 Oramed Pharmaceuticals Inc. (NASDAQCM: ... delivery systems, announced today that the United States Food ... New Drug application(IND) for ORMD-0801, its oral insulin capsule. ... FDA clearance to proceed," stated Nadav Kidron ... a major milestone for Oramed and we look forward ...
(Date:5/17/2013)... May 17, 2013  Boston Scientific Corporation (NYSE: ... annual EuroPCR Scientific Program May 21-24 in ... present a particularly rich and diversified set of data ... , M.D., global chief medical officer, Boston Scientific.  ... presented, including the NG PROMUS trial, which evaluated our ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
Cached News: